Evan B Cunningham (Evan Cunningham, E B Cunningham)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Venues

Journal of viral hepatitis

Drug and alcohol review

Open forum infectious diseases

Liver international : official journal of the International Association for the Study of the Liver

University of New South Wales (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of New South Wales Mar 27 2014

Australia

PHD :: Medicine

University of Manitoba Sep 01 2009 - May 01 2013

Canada

BSC :: Biotechnology

Publications

Abdullah Farooq, Heather Valerio, Alice Wheeler, Marianne Martinello, Charles Henderson, David Silk, Louisa Degenhardt, Phillip Read, Gregory J Dore, Jason Grebely, Evan B Cunningham, null null
Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study. Drug and alcohol review (2024)
Hannah Ryan, Gregory J Dore, Jason Grebely, Marianne Byrne, Evan B Cunningham, Marianne Martinello, Andrew R Lloyd, Behzad Hajarizadeh
Hepatitis C treatment outcome among people in prison: The SToP-C study. Liver international : official journal of the International Association for the Study of the Liver (2024)
Abdullah Farooq, Heather Valerio, Alice Wheeler, Marianne Martinello, Charles Henderson, David Silk, Louisa Degenhardt, Phillip Read, Gregory J Dore, Jason Grebely, Evan B Cunningham, null null
Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study. Drug and alcohol review 43 (4) (2024)
Abdullah Farooq, Heather Valerio, Alice Wheeler, Marianne Martinello, Charles Henderson, David Silk, Louisa Degenhardt, Phillip Read, Gregory J Dore, Jason Grebely, Evan B Cunningham, null null
Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study. Drug and alcohol review 43 (4) (2024)
Sophy Ting-Fang Shih, Jack Stone, Natasha K Martin, Behzad Hajarizadeh, Evan B Cunningham, Jisoo A Kwon, Colette McGrath, Luke Grant, Jason Grebely, Gregory J Dore, Andrew R Lloyd, Peter Vickerman, Georgina M Chambers
Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination. Open forum infectious diseases 11 (2) (2023)
Sophy Ting-Fang Shih, Jack Stone, Natasha K Martin, Behzad Hajarizadeh, Evan B Cunningham, Jisoo A Kwon, Colette McGrath, Luke Grant, Jason Grebely, Gregory J Dore, Andrew R Lloyd, Peter Vickerman, Georgina M Chambers
Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination. Open forum infectious diseases 11 (2) (2023)
Behzad Hajarizadeh, Joanne M Carson, Marianne Byrne, Jason Grebely, Evan B Cunningham, Janaki Amin, Peter Vickerman, Natasha K Martin, Carla Treloar, Marianne Martinello, Andrew R Lloyd, Gregory J Dore, null null
Incidence of hepatitis C virus infection in the prison setting: The SToP-C study. Journal of viral hepatitis (2023)
Jason Grebely, Phillip Read, Evan B Cunningham, Martin Weltman, Gail V Matthews, Adrian Dunlop, Mark Montebello, Marianne Martinello, Rosie Gilliver, Philippa Marks, Tanya L Applegate, Gregory J Dore, null null
Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial. Health science reports 3 (2) (2020)
Phillip Read, Rosie Gilliver, John Kearley, Rebecca Lothian, Evan B Cunningham, Karen J Chronister, Gregory J Dore
Treatment adherence and support for people who inject drugs taking direct-acting antiviral therapy for hepatitis C infection. Journal of viral hepatitis 26 (11) (2019)
Jason Grebely, Sarah Larney, Amy Peacock, Samantha Colledge-Frisby, Janni K Y Leung, Matthew Hickman, Peter Vickerman, Sarah Blach, Evan B Cunningham, Konstantin Dumchev, Michael T Nurmohamed, Jack Stone, Adam Trickey, Homie Razavi, Richard P Mattick, Michael Farrell, Gregory J Dore, Louisa Degenhardt
Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. Addiction (Abingdon, England) 114 (1) (2018)
Jisoo A Kwon, Gregory J Dore, Jason Grebely, Behzad Hajarizadeh, Rebecca J Guy, Evan B Cunningham, Cherie Power, Chris Estes, Homie Razavi, Richard T Gray, null null
Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study. Journal of viral hepatitis 26 (1) (2018)
Evan B Cunningham, Behzad Hajarizadeh, Olav Dalgard, Janaki Amin, Margaret Hellard, Graham R Foster, Philip Bruggmann, Brian Conway, Markus Backmund, Geert Robaeys, Tracy Swan, Philippa S Marks, Sophie Quiene, Tanya L Applegate, Martin Weltman, David Shaw, Adrian Dunlop, Julie Bruneau, Håvard Midgard, Stefan Bourgeois, Maria Christine Thurnheer, Gregory J Dore, Jason Grebely, null null
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study. BMC infectious diseases 17 (1) (2017)
Evan B Cunningham, B Hajarizadeh, N A Bretana, J Amin, B Betz-Stablein, G J Dore, F Luciani, S Teutsch, K Dolan, A R Lloyd, J Grebely, null null
Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study. Journal of viral hepatitis 24 (9) (2017)

Evan B Cunningham.css-eqlu8i{font-size:small;padding-left:4px;} (Evan Cunningham, E B Cunningham)

Publication Activity (10 Years)

Top Topics

Top Venues

Evan B Cunningham (Evan Cunningham, E B Cunningham)